Milameline
Introduction '''Milameline''' ('''CI-979''', '''PD-129,409''', '''RU-35,926''') is a non-selective muscarinic acetylcholine receptor partial agonist with cognition-acting properties that was being investigated for the treatment of Alzheimer's disease, but produced poor results in clinical trials and was subsequently discontinued. *Changing the ''O''-methyl aldoxime to an ''O''-propargyl oxime instead gives a separate molecule called RU 35986.
See also * Alvameline* Sabcomeline* Tazomeline* Xanomeline
References